CIK 0001285819
- Non-accelerated filer
- Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911663741
- Phone
- +1 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 10,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CHAIRMAN, CEO & PRESIDENT sold 73,713 shares at an average $14.96 ($1,102,746)
- 4 Open-market sale CHAIRMAN, CEO & PRESIDENT sold 73,713 shares at an average $16.02 ($1,180,515)
- 4 Open-market sale CHAIRMAN, CEO & PRESIDENT sold 72,613 shares at an average $17.84 ($1,295,218)
- 4 Exercise or conversion Director acquired 10,000 shares (option exercise)
- 4 Open-market sale VP FINANCE AND CAO sold 18,100 shares at an average $22.93 ($414,968)
- 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
- 4 Open-market sale VP FINANCE AND CAO sold 1,900 shares at $22.49 ($42,731)
- 4 Open-market sale VP FINANCE AND CAO sold 9,500 shares at $19.95 ($189,525)
- 4 Open-market sale Director sold 5,000 shares at $16.97 ($84,850)
- 4 Derivatives Options or other derivatives
Page 5 of 15 · 295 filings